Company Monitoring Page for Eisai

latest headlines for company on cafepharma

This Week in Biotech: Part 2
Motley Fool
Sun, 11/11/12 - 09:19 am
Tags:
Biocryst, Catalyst Pharmaceutical Partners, Pluristem Therapeutics, Vivus, Arena Pharmaceuticals, Eisai
FDA approves Eisai's drug to treat epileptic seizures
Yahoo/Reuters
Tue, 10/23/12 - 09:19 am
Tags:
FDA, Eisai, epilepsy, seizures, Fycompa
3 Reasons Why Eisai Should Purchase Arena Pharmaceuticals
Motley Fool
Wed, 10/17/12 - 11:51 am
Tags:
Arena Pharmaceuticals, Eisai, Belviq
Eisai’s Epilepsy Drug Helps Obese Patients Reduce Weight
Bloomberg
Wed, 10/17/12 - 11:20 am
Tags:
Eisai, epilepsy, obesity, Zonegran
Is Alzheimer's Research the Next Big Thing in Biotech?
Motley Fool
Thu, 10/11/12 - 10:47 am
Tags:
Alzheimer's disease, Eisai, Forest Labs, JNJ, Pfizer, Eli Lilly, Roche
Vivus Launches Qsymia - What To Look For Now
Seeking Alpha
Tue, 09/18/12 - 11:28 am
Tags:
Vivus, Qsymia, Arena Pharmaceuticals, Eisai
Heroes And Zeros: Arena Pharmaceuticals And Avanir Pharmaceuticals
Seeking Alpha
Mon, 09/17/12 - 10:53 am
Tags:
Arena Pharmaceuticals, Avanir, Eisai
Should Arena Hold Off On New Marketing And Supply Agreements?
Seeking Alpha
Thu, 08/23/12 - 09:59 am
Tags:
Belviq, Arena Pharmaceuticals, Eisai
Eisai CEO Sees 'Huge' Medical Need for New Diet Drug
WSJ Online
Wed, 08/15/12 - 11:15 am
Tags:
Eisai, obesity, Haruo Naito, Belviq, Arena Pharmaceuticals
Arena Pharmaceuticals transfers diet pill marketing rights to Japanese partner Eisai
Yahoo/AP
Mon, 07/30/12 - 12:23 pm
Tags:
Belviq, Arena Pharmaceuticals, Eisai
Partnership and Acquisition in the Red Hot Weight Loss Market
Motley Fool
Mon, 07/16/12 - 08:45 am
Tags:
Vivus, Arena Pharmaceuticals, obesity, M&A, Qnexa, Belviq, Pfizer, JNJ, Eisai
Eisai's Halavan misses endpoints in Phase III trial
Pharma Times, UK
Wed, 07/11/12 - 10:06 am
Tags:
Eisai, Halavan, Xeloda, breast cancer
Aricept Drug Dosage Was Approved Despite Warning
NY Times, NY
Fri, 03/23/12 - 11:28 am
Tags:
Aricept, Alzheimer's disease, FDA, Pfizer, Eisai
Eisai gets bad news for Dacogen but excitement over Alzheimer study
Pharma Times, UK
Fri, 02/10/12 - 10:55 am
Tags:
Dacogen, Alzheimer's disease, Eisai, Astex, Targretin
Eisai renews focus on 'more attractive' Japan
Fierce Pharma
Wed, 02/8/12 - 03:15 pm
Tags:
Eisai, Japan
Astex Falls Most Since 2004 as FDA Questions Drug
Bloomberg
Tue, 02/7/12 - 06:05 pm
Tags:
FDA, Astex, Eisai, Dacogen
Auxilium recieves cautious assessment for Xiaflex, says Leerink
Yahoo/Fly on the Wall
Wed, 02/1/12 - 11:33 am
Tags:
Auxilium, Xiaflex, Pfizer, Dupuytren's Contracture, breast cancer, Eisai, Halaven
Top 10 pharma layoffs of 2011
Fierce Pharma
Wed, 01/4/12 - 09:37 am
Tags:
Merck, Pfizer, Abbott Laboratories, Novartis, AstraZeneca, Teva Pharmaceuticals, Sanofi, JNJ, Eisai, Bayer
Eisai First-Half Profit Falls 17% as Aricept Sales Decline
Bloomberg
Tue, 11/1/11 - 12:22 pm
Tags:
Eisai, earnings
Suit accuses pharma companies of Medicaid price-data manipulation
Philly.com
Sat, 10/8/11 - 12:51 pm
Tags:
Upsher-Smith, Sunovion, Reliant, NovoNordisk, Medicaid fraud, Mallinckrodt, legal, Genzyme, Eisai, Cephalon, Bradley, Biogen, AstraZeneca, Amgen, Allergan

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.